Histopathological and biological prognostic risk factors in low stage testicular nonseminomatous germ cell tumors;Histopathologische und biologische prognosefaktoren nichtseminomatoser keimzell-tumoren im klinischen stadium I. Implikationen fur eine risikoadaptierte therapie

Urologe - Ausgabe A

Volumn 38, Issue 2, 1999, Pages 168-178

  Heidenreich, A ^a   Sesterhenn, I A ^b   Mostofi, F K ^a   Moul, J W ^c   Engelmann, U H ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

bcl 2; Cathepsin D; E cadherin; Embryonal carcinoma; Nonseminomatous germ cell tumor; p53; Prognosis; Vascular invasion

Indexed keywords

CATHEPSIN; PROTEIN BCL 2; PROTEIN P53; UVOMORULIN; TUMOR MARKER;

ARTICLE; CANCER GRADING; CANCER INVASION; EMBRYONAL CARCINOMA; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; PROGNOSIS; TESTIS BIOPSY; ENZYME IMMUNOASSAY; LYMPH NODE; LYMPH NODE METASTASIS; MULTIMODALITY CANCER THERAPY; NEOPLASM; PATHOLOGY; RISK; SEMINOMA; TESTIS TUMOR; TUMOR EMBOLISM;

COMBINED MODALITY THERAPY; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; LYMPHATIC METASTASIS; MALE; NEOPLASM CIRCULATING CELLS; NEOPLASM INVASIVENESS; NEOPLASMS, GERM CELL AND EMBRYONAL; PROGNOSIS; RISK; SEMINOMA; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032920428     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001200050262     Document Type: Article

References (36)

1. Albers P, Bierhoff E, Neu D, Fimmers R, Wernert, N, Müller SC (1997) MIB-1 immunohistochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis. Cancer 79: 1710-1716
2. Andersson AM, Edvardsen K, Skakkebaek NE (1994) Expression and localization of N-and E-cadherin in the human testis and epididymis. Int J Androl 17: 174-178
3. Chresta CM, Masters JRW, Hickman JA (1996) Hypersensitivity of human testicular tumors to etoposide induced apoptosis is associated with functional p53 and a high bax:bcl-2 ratio. Cancer Res 56: 1834-1841
4. DeRiese WTW, Orazi A, Foster RS, Donohue JP, Messemer JE (1993) The clinical relevance of p53 expression in early stage nonseminomatous germ cell tumors. J Urol 149: 311A
5. Fernandez EB, Sesterhenn IA, McCarthy WF, Mostofi F, Moul JW (1994) Proliferating cell nuclear antigen expression to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors. J Urol 152: 1133-1138
6. Freedman LS, Jones WG, Peckham MJ, New-lands ES, Parkinsom MC, Oliver RTD., Read G, Williams G (1987) Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchiectomy alone. Lancet 2: 294-298
7. Friedman NB, Moore RA (1946) Tumors of the testis: a report of 922 cases. Milit Surg 99: 573
8. Medinger C (1981) 2. Tutorial: Spezielle Pathologie der Schilddrüsenerkrankungen. Hannover, Deutschland, 1981
9. Heidenreich A, Sesterhenn IA, Moul JW (1997) Prognostic risk factors in low stage testicular germ cell tumors. Cancer 79: 1641-1645
10. Heidenreich A, Schenkmann NS, Sesterhenn IA, Mostofi FK, Moul JW (1997) Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumors. J Urol 158: 620-625
11. Heidenreich A, Schenkman NS, Sesterhenn IA, Mostofi FK, Srivastava S, Moul JW (1998) Immunohistochemical and mutational analysis of the p53 tumor suppressor gene and the bcl-2 oncogene in testicular germ cell tumors. APMIS 106: 90-100
12. Hoeltl W, Kosak D, Pont J, Hawel R, Machacek E, Schempfer M, Honetz N, Marberger M (1987) Testicular cancer: prognostic implications of vascular invasion. J Urol 137: 683-685
13. Jiang WG (1996) E-cadherin and its associated protein catenins, cancer invasion and metastasis. Br J Surg 83: 437-446
14. Klepp O, Olsson AM, Henrikson H, Aass N, Dahl O, Stenwig AE, Persson BE, Cavallin-Stahl E, Fossa SD, Wahlqvist L (1990) Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. J Clin Oncol 8: 509-518
15. Kratzik C, Höltl W, Albrecht W, Pont J, Zielinski Ch, Breindl E, Pummer K, Hubmer G, Marberger M (1996) Risk adapted management for NSGCT stage I - longterm results of a multicenter study. J Urol 155 [Suppl]: 547A
16. Kuczyk MA, Serth J, Bokemeyer C, Jonassen J, Machtens S, Werner M, Jonas U (l 996) Alterations of the p53 tumor suppressor gene in carcinoma in situ of the testis. Cancer 78: 1958-1967
17. Lewis DJ, Sesterhenn IA, McCarthy WF, Moul JW (1994) Immunohistochemical expression of p53 tumor suppressor gene protein in adult testicular germ cell testis tumors: clinical correlation in stage I disease. J Urol 152: 418-423
18. Madej G, Wiechno PJ, Paluchowska B (1997) Risk-related adjuvant chemotherapy in stage I germ cell tumor of the testis-failure analysis. J Urol 157 [Suppl]: 304
19. Metz CE (1978) Basic principles of ROC analysis. Semin Nucl Med 8: 283-298
20. Morton RA, Ewing CM, Nagafuchi A, Tsukita S, Issacs WB (1993) Reduction of e-cadherin levels and deletion of the α-catenin gene in human prostate cancer cells. Cancer Res 53: 3585-3589
21. Moul JW, McCarthy WF, Fernandez EB, Sesterhenn IA (1994) Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer. Cancer Res 54: 362-364
22. Moul JW, Heidenreich A (1996) Prognostic factors in low stage nonseminomatous testicular cancer. Oncology 10: 1359-1378
23. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, Takatskua Y, Matsuyoshi N, Hironon S, Takeichi M, Mori T (1993) Expression of E-Cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 53: 1696-1701
24. Peckham MJ, Barrett A, Husband JE et al (1982) Orchiectomy alone in testicular stage I nonseminomatous germ cell tumors. Lancet 2: 678-680
25. Peng HQ, Hogg D, Malkin D, Bailey D, Gallie BL, Bulbul M, Jewett M, Buchanan J, GOSS PE (1993) Mutations of the p53 gene do not occur in testis cancer. Cancer Res 53: 3574-3578
26. Pont J, Höltl W, Kosak D, Machacek E, Kienzer H, Julcher H, Honetz N (1990) Risk adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial. J Clin Oncol 8: 16-20
27. Rochefort H, Liaudet E, Garcia M (1996) Alterations and role of human cathepsin D in cancer metastasis. Enz Prot 49: 106-119
28. Scherenberg M, Schubert GE (1993) Morphologische Kriterien zur Beurteilung β-hCG positiver Seminome. Urologe [A] 32: 38-42
29. Sesterhenn IA, Weiss RB, Mostofi FK, Stablein DM, Rowland RG, Falkson G, Rivkind SE, Vogelzang NJ (1992) Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study. J Clin Oncoll 10:69-78
30. Strohmeyer T, Fleischhacker M, Imai Y, Slamon DJ, Koeffler HP (1993) Status of the p53 tumor suppressor gene and the MDM2-gene in human testicular tumors. JUrol 149: 311A
31. Takeichi M (1981) Cadherin cell adhesion receptors as a morphogenic regulator. Science 251: 1451-1453
32. Tandon AK, Clark GM, Chamness GC, Chrigwin JM, McGuire WL (1990) Cathepsin D and prognosis in breast cancer. N Engl J Med 322: 297-302
33. Tsujimoto Y, Cossman J, Jaffe E, Croce C (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science 228: 1440-1442
34. Umbas R, Schalken J, Aalders TW, Carter BS, Karthaus HFM, Schaafsma HE, Debruyne FMJ, Issaacs WB (1992) Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high grade prostate cancer. Cancer Res 52: 5104-5109
35. Ulbright T, Orazi A, deRiese W, Messemer JE, Eble J (1993) The relationship of p53, PCNA, and S-phase in nonseminomatous germ cell tumors of the testis. Lab Invest 68: 71A
36. Wu JC, Gregory CW, DePhilip RM (1993) Expression of e-cadherin in immature rat and mouse testis and in rat Sertoli cell cultures. Biol Reprod 49: 1353-1357